Healthcare -
Biotechnology - NYSE - US
$ 10.83
6.18 %
$ 622 M
Market Cap
-0.77
P/E
DNA - CHANGE IN WORKING CAPITAL
Change in Working Capital DNA - Ginkgo Bioworks Holdings, Inc.
29.8 M
LAST VALUE
57.63%
2 YEAR CAGR
-11.52%
5 YEAR CAGR
0.00%
10 YEAR CAGR